GI
CRBP icon

GAMMA Investing’s Corbus Pharmaceuticals CRBP Stock Holding History

GAMMA Investing’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.79K Buy
556
+220
+65% +$2.03K ﹤0.01% 3760
2026
Q2 		$3.15K Hold
336
– – ﹤0.01% 3634
2026
Q1 		$3.15K Sell
336
-50
-13% -$421 ﹤0.01% 3539
2025
Q4 		$3.14K Hold
386
– – ﹤0.01% 3462
2025
Q3 		$4.88K Buy
386
+50
+15% +$476 ﹤0.01% 3194
2025
Q2 		$2.32K Sell
336
-120
-26% -$872 ﹤0.01% 3367
2025
Q1 		$2.42K Buy
456
+250
+121% +$2.21K ﹤0.01% 3355
2024
Q4 		$2.43K Buy
206
+196
+1,960% +$3.29K ﹤0.01% 3161
2024
Q3 		$206 Buy
+10
New +$512 ﹤0.01% 3495

Other funds holding CRBP

DA
Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

GAMMA Investing's CRBP Position: Q3 2026 in Review

GAMMA Investing increased its Corbus Pharmaceuticals (CRBP) stake by 65% in Q3 2026, buying an estimated $2.03K and bringing the position to 556 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #3760.

GAMMA Investing first reported a position in CRBP in Q3 2024 and has held it in 9 quarters since. The position peaked at $4.88K in Q3 2025. 6 funds tracked by Wall St. Rank hold CRBP as of Q3 2026.

  • GAMMA Investing held 556 shares of Corbus Pharmaceuticals worth $3.79K as of Q3 2026.
  • GAMMA Investing bought 220 Corbus Pharmaceuticals shares in Q3 2026, an estimated $2.03K.
  • Corbus Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3760 holding.
  • GAMMA Investing first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • GAMMA Investing's Corbus Pharmaceuticals position peaked at $4.88K in Q3 2025.
  • 6 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.